ClinVar Miner

Submissions for variant NM_001267550.2(TTN):c.13357_13358del (p.Glu4453fs)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV004018367 SCV004848130 likely pathogenic Primary dilated cardiomyopathy 2018-07-25 criteria provided, single submitter clinical testing The p.Glu4215fs variant in TTN has not been previously reported in individuals with DCM and was absent from large population studies, though the ability of these studies to accurately detect indels may be limited. This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 4215 and leads to a premature termination codon 7 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Frameshift and other truncating variants in TTN are strongly associated with DCM if they impact the exons encoding for the A-band (Herman 2012, Pugh 2014) and/or are located in an exon that is highly expressed in the heart (Roberts 2015). The p.Glu4215fs variant is located in the highly expressed exon 46 in the I band. In summary, although additional studies are required to fully establish its clinical significance, the p.Glu4215fs variant is likely pathogenic. ACMG/AMP Criteria applied: PVS1_Strong; PM2.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.